Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 0 | 0 | 4,990 | 0 |
| Gross Profit | N/A | N/A | N/A | 4,990 | N/A |
| Operating Expenses | 7,553 | 7,289 | 7,588 | 11,914 | 11,340 |
| Operating Income | -7,553 | -7,289 | -7,588 | -6,924 | -11,340 |
| Interest Expense | 0 | 0 | 129 | 125 | 131 |
| Other Income | 371 | -1,278 | 4,463 | 3,551 | -762 |
| Pre-tax Income | -7,182 | -8,567 | -3,254 | -3,498 | -12,233 |
| Income Tax | 6 | 72 | 225 | 379 | 96 |
| Net Income Continuous | -7,188 | -8,639 | -3,479 | -3,877 | -12,329 |
| Net Income | $-7,188 | $-8,639 | $-3,479 | $-3,877 | $-12,329 |
| EPS Basic Total Ops | -0.27 | -0.32 | -0.13 | -0.15 | -0.46 |
| EPS Basic Continuous Ops | -0.27 | -0.32 | -0.13 | -0.14 | -0.46 |
| EPS Diluted Total Ops | -0.27 | -0.32 | -0.13 | -0.15 | -0.46 |
| EPS Diluted Continuous Ops | -0.27 | -0.32 | -0.13 | -0.14 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.32 | -0.13 | -0.14 | -0.46 |
| EBITDA(a) | $-6,443 | $-7,825 | $-8,044 | $-7,438 | $-11,917 |